This announcement is a separate document:
锦天城（杭州）关于迈得医疗调整2021年限制性股票激励计划授予价格和授予数量及2021年限制性股票激励计划首次授予部分第二个归属期及预留授予部分第一个归属期归属条件成就及部分限制性股票作废的法律意见书
AllBright (Hangzhou)\'s legal opinion on Maide Healthcare\'s adjustment of the 2021 restricted stock incentive plan grant price and number of grants and the achievements of the 2021 restricted stock incentive plan for part of the second vesting period for
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.